Monday, June 17, 2024
HomeTagsAnti-Tumor

Anti-Tumor

Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics